Buy or sell PrognomiQ stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
PrognomiQ Stock
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
About PrognomiQ Stock
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
Funding History
| September 2020 | $55.0M |
|---|---|
| March 2022 | $46.0M |
Management
Interim CFO
David Siewers
Chief Executive Officer, President & Founder
Philip Ma
Co-Founder & Chairman
Omid Farokhzad
Board of Director
Tomer Berkovitz
Distinguished Scientist
John E. Blume
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
